To Compare Pharmacokinetics, Efficacy, and Safety of CT-P17 With Humira in Patients With Moderate to Severe Chronic Plaque Psoriasis
Condition:   Moderate to Severe Chronic Plaque Psoriasis Interventions:   Biological: CT-P17;   Biological: EU-approved Humira Sponsor:   Celltrion Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 10, 2022 Category: Research Source Type: clinical trials

Proactive Therapeutic Drug Monitoring Based Adalimumab Therapy Optimization in Patients With Rheumatoid Arthritis
Condition:   Rheumatoid Arthritis Intervention:   Other: Therapeutic drug monitoring (TDM) Sponsors:   Boston Medical Center;   American Society of Health-System Pharmacists Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 15, 2022 Category: Research Source Type: clinical trials